94 related articles for article (PubMed ID: 21334045)
1. The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning.
Patel V; Merrick GS; Allen ZA; Andreini H; Taubenslag W; Singh S; Butler WM; Adamovich E; Bittner N
Urology; 2011 May; 77(5):1148-52. PubMed ID: 21334045
[TBL] [Abstract][Full Text] [Related]
2. The morbidity of transperineal template-guided prostate mapping biopsy.
Merrick GS; Taubenslag W; Andreini H; Brammer S; Butler WM; Adamovich E; Allen Z; Anderson R; Wallner KE
BJU Int; 2008 Jun; 101(12):1524-9. PubMed ID: 18325064
[TBL] [Abstract][Full Text] [Related]
3. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
4. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
[TBL] [Abstract][Full Text] [Related]
5. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy.
Satoh T; Matsumoto K; Fujita T; Tabata K; Okusa H; Tsuboi T; Arakawa T; Irie A; Egawa S; Baba S
Urology; 2005 Jul; 66(1):114-8. PubMed ID: 15992910
[TBL] [Abstract][Full Text] [Related]
6. Acute urinary retention after transperineal template-guided prostate biopsy.
Buskirk SJ; Pinkstaff DM; Petrou SP; Wehle MJ; Broderick GA; Young PR; Weigand SD; O'Brien PC; Igel TC
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1360-6. PubMed ID: 15275721
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
Merrick GS; Gutman S; Andreini H; Taubenslag W; Lindert DL; Curtis R; Adamovich E; Anderson R; Allen Z; Butler W; Wallner K
Eur Urol; 2007 Sep; 52(3):715-23. PubMed ID: 17337114
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of transrectal needle biopsy of the prostate: usefulness of systematic 12 core biopsy].
Imazu T; Yokoyama S; Fukuhara S; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2007 Jun; 53(6):365-8. PubMed ID: 17628932
[TBL] [Abstract][Full Text] [Related]
9. [On extended biopsy of the prostatic gland].
Chepurov AK; Vladimirov VG; Zarinskaia SA; Meshkov VV; Kobaladze KM; Iremashvili VV
Urologiia; 2010; (1):52-5. PubMed ID: 20886732
[TBL] [Abstract][Full Text] [Related]
10. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic transperineal prostate biopsy.
Moran BJ; Braccioforte MH
Urology; 2009 Feb; 73(2):386-8. PubMed ID: 19027936
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
[TBL] [Abstract][Full Text] [Related]
13. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
14. Transrectal ultrasound-guided transperineal biopsy: a histologic and cytologic comparison for the diagnosis of prostate cancer.
Lee F; Torp-Pedersen S; Soiderer MH; Kumasaka GH; Littrup PJ; McHugh TA; Schmitter SP; Chang TT; Meyer-Haass GM
Prog Clin Biol Res; 1989; 303():11-7. PubMed ID: 2674979
[No Abstract] [Full Text] [Related]
15. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.
Kawakami S; Okuno T; Yonese J; Igari T; Arai G; Fujii Y; Kageyama Y; Fukui I; Kihara K
Eur Urol; 2007 Mar; 51(3):675-82; discussion 682-3. PubMed ID: 16843585
[TBL] [Abstract][Full Text] [Related]
16. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk.
Igel TC; Knight MK; Young PR; Wehle MJ; Petrou SP; Broderick GA; Marino R; Parra RO
J Urol; 2001 May; 165(5):1575-9. PubMed ID: 11342920
[TBL] [Abstract][Full Text] [Related]
17. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy.
Emiliozzi P; Scarpone P; DePaula F; Pizzo M; Federico G; Pansadoro A; Martini M; Pansadoro V
J Urol; 2004 Jan; 171(1):197-9. PubMed ID: 14665875
[TBL] [Abstract][Full Text] [Related]
18. [Transperineal prostatic biopsy guided by ultrasound].
Xu YM
Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):231-2, 254. PubMed ID: 2478348
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
Rabbani F
Eur Urol; 2007 Sep; 52(3):723-4. PubMed ID: 17337115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
